Patent · US Active

CRISPR/Cas screening platform to identify genetic modifiers of tau seeding or aggregation

US11845931B2 · kind B2 · utility

4Cited by
3References
37Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 17, 2020
Grant dateDec 19, 2023
Priority date
Expiry dateMay 4, 2042

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/7047
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Cas-protein-ready tau biosensor cells, CRISPR/Cas synergistic activation mediator (SAM)-ready tau biosensor cells, and methods of making and using such cells to screen for genetic modifiers of tau seeding or aggregation are provided. Reagents and methods for sensitizing such cells to tau seeding activity or tau aggregation or for causing tau aggregation are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.